$20.700
-0.733 (-3.54%)Al cierre
Comparativa sectorial de ATTO
In the context of the broader market, ATTO competes directly with industry leaders such as IVA and DSGN. With a market capitalization of $923.40M, it holds a significant position in the sector. When comparing efficiency, ATTO's gross margin of N/A stands against IVA's 100.00% and DSGN's N/A. Such benchmarking helps identify whether Attovia Therapeutics Inc is trading at a premium or discount relative to its financial performance.
Desempeño financiero de Attovia Therapeutics Inc
Attovia has shown a gross margin of 0% for Q1 2026, indicating no revenue generation yet, but it has a strong current ratio of 13.94, suggesting good liquidity. The forward P/E ratio of 4.81 indicates potential for future earnings growth.
Financials
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.